Obligation Barclay PLC 5% ( US06738JAZ75 ) en USD

Barclay PLC

100 % ▼

Royaume-Uni

US06738JAZ75 ( en USD )

5% par an ( paiement semestriel )

28/04/2023 - Obligation échue

Prospectus brochure de l'obligation Barclays PLC US06738JAZ75 en USD 5%, échue

1 000 USD

2 118 000 USD

06738JAZ7

A ( Qualité moyenne supérieure )

A1 ( Qualité moyenne supérieure )

Barclays PLC est une banque multinationale britannique offrant une large gamme de services financiers, notamment la banque de détail, la gestion de patrimoine, la banque d'investissement et les cartes de crédit, opérant dans de nombreux pays à travers le monde.

L'Obligation émise par Barclay PLC ( Royaume-Uni ) , en USD, avec le code ISIN US06738JAZ75, paye un coupon de 5% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 28/04/2023

L'Obligation émise par Barclay PLC ( Royaume-Uni ) , en USD, avec le code ISIN US06738JAZ75, a été notée A1 ( Qualité moyenne supérieure ) par l'agence de notation Moody's.

L'Obligation émise par Barclay PLC ( Royaume-Uni ) , en USD, avec le code ISIN US06738JAZ75, a été notée A ( Qualité moyenne supérieure ) par l'agence de notation Standard & Poor's ( S&P ).

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 1 of 12
424B2 1 d424b2.htm PRICING SUPPLEMENT BARC 13YR 5.00% WITH SURVIVOR'S OPTION BLACK
CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered
Maximum Aggregate Offering Price
Amount of Registration Fee(1)
Global Medium-Term Notes, Series A
$2,118,000
$151.01
(1)
Calculated in accordance with Rule 457(r) of the Securities Act of 1933.
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 2 of 12
Pricing Supplement dated April 23, 2010
Filed Pursuant to Rule 424(b)(2)
(To Prospectus dated February 10, 2009 and
Registration No. 333-145845
the Prospectus Supplement dated March 1, 2010)

http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 3 of 12
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 4 of 12

B
ore$usic A
De
Or
Afe
No
n2s RCLAYS
nominatio
iginal
nnually
the
tes
try;
9a
itial N
quest
lli
652
s otes
nThe
a
or
ecurities ny
$2
ac
ale o
onfirmationr
f US$2
ns:
Trade
Awe
088
porN
of M
D
ight
Transferabsle
348
tion
otes
ale118
inim
ate:
nnually
will
to
calenda
or(f
ommissionIty
1)
tn 00
um
April
repay
ear
has
his p0
hese2
payat
Listing:
a
addit 5
de3
exercise
Barcla
i 00%
ble
For
onin
hose
thisa
The
ys
ricing a
N
o
dd
N
pprovedFIXED
nominations
2010rrea
p
otes
Capi
commissor r
otes s
tion
tal
ions
d
Barclayso
w
itionalI
supplem d
will
to R
of
CUSIP:
n
prior
ill
nc
ent ATE
US$1
every
tio
be
be
pay
s the
etails
not
will
s
isapprove
Capital
b INOTES
d0
re 0
o
nc
eing 0
28th
subject
elling
f t a
06738JAZ7
listedc
or nd
o
ceiveIf
Maturi
to:
regarding
on
used DUE
SIN:
A
ty·
hese pril
ta
a
in p
he
ny
anothe
a rmApril
integr
Dateal
an
Uo d
S
oncessionsf O
commissions
or
securities
our
arket 2
mul
ermitted
Survivor
or 8
cto
followri'b
ds
fees
d 2023
tiples
US06738JAZ
er
ng
O
securitie
fromt
esale t
o o
ollars f
75
theae
he
affiliatesPrincipal
U
B
d
ption S$1
u
other
etermine
m
ransasiness
commen
eath
mount
see
xcha
d
c t
ay co
Issuer f
"
nge
eale
hat
tion t
of
Dr
use A
000
inghe
eor
st* mount:
Dao
equaly:
n
tota
T
his lt
his o
p
For
O
e
he
p xer
scription
quota
1
ri
fur U
thereafter
ctob
co
tion
ricing
cingS$2
f
Notes
therI
New
er
beneficials
40% i Y
28
ises
Sof
w
sup
n 118
ssuer:
ork
illp 2
owner
by
yste all
m
the 000
B

010
o
p
not
suppleme f
urvivor'
Pn ts
rinc
be
t
lementi
formationIssu
arclays
and
he
O
rices t
inr e
N
holders
to
ipal e
Londooa
listed
egarP
Bn
of
ption"
Pum
o rice
ank
nding
tesn
ruthfulp
b
markete
blic
ao
ding :
P
Eu
on
these
ount
ny
r 100%
LC
rco
the
N
low
Ag
of
U
resale
the r M
rovided
otes
B
ent
S '
the Origi
(Rated
Os
atin ther
uch
in
usiness
C
notes
omplete
gs
n
A(
aturity
N
anyal
AA
D
ommi
or
securities
ny Issu
/
transactionsA
otes
aye
assigne a
Date
$14
repr
ind te
ssion )
es
an
o D
3)*
xchaI
were
calendar
00y ate
S
nt
Survi
y
(1) P
p
thee
nge
N :
ear
rG April
eries:
erest
vor;
or '
acquir
$a
Convention:
roce
1
entation
otes R
st a
O
ed
nd
eds
o
af
lobal t2
t·t
000
ter 8
e:
byto
quotati
he
Mt5
h
po 2010
Globale
Follow M
00%
ption:
the
hep
i
Bn
co d
s
ir e
er
ng
edium Inter
edium
Upon
arclay
rincipal
init
T s
ystem
ntrarye B
is
ial
rme
ceased
mitteda
s s
T
N t
e
Interestc
ale R
rm
request
Unadjuste
ank
amount ate
Pby
dollar
da
either
U
Notes aP T
LC
nd
riminal
r ype
Notes
Paymen
beneficia
Day
thel
m
nless t
theo a
C
Pera
Sw :
SD
mount
ye F
Nr
ffeno
ogram ixed
eries
ate
of
ount
etsr s
owner
otee :aA
at
n
10
ain
ecurities
W
ourRate
lae
Serie M
uthorizedeast
indiv
0%
ll
am
s 1
or
nd
A Maturity
Principal
onthly
represe
s
i
ay
agentix
dual
Conventio
as n:
p
i o
use
ee "P
n
mo
e
30/3
40%rt98
tion
Exchange
his
nforms
Pr Date:
rotectio
Qu
6p a
tative
nths0
ofro
ri f
xercise
S
%t
you
ogram n
te
prirt
boA
l
ory
ettl
To
cingt pril
Py
het
hese
Commi
o
aalt
sup
Credit 28
erce
benef
he
ement:
$2
ssion
p i
comm
herwise 2023
ntage:
Semi
cial
date
holderi o
118
norn ft
Rating 100%
lementowner
of
t
DTC;
h"e the
hese
Book
000
issions
any
in
beor
state
th
l e
ow
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 5 of 12
The Notes constitute our direct, unconditional, unsecured and unsubordinated obligations and are not deposit liabilities of Barclays Bank PLC and are not insured by
the U.S. Federal Deposit Insurance Corporation or any other governmental agency of the United States, the United Kingdom or any other jurisdiction.
Investing in the Notes involves a number of risks. See "Risk Factors" beginning on page S-5 of the prospectus supplement and "Selected Risk Factors" below. We urge
you to consult your investment, legal, tax, accounting and other advisers and to invest in the Notes only after you and your advisors have carefully considered the
suitability of an investment in the Notes in light of your particular circumstances.
Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this pricing supplement relates. Before you invest,
you should read the prospectus dated February 10, 2009, the prospectus supplement dated March 1, 2010, and other documents Barclays Bank PLC has filed with the
SEC for more complete information about Barclays Bank PLC. and this offering. Buyers should rely upon this pricing supplement, the prospectus, the prospectus
supplement, and any relevant free writing prospectus or pricing supplement for complete details. You may get these documents and other documents Barclays Bank
PLC has filed for free by visiting EDGAR on the SEC website at www.sec.gov, and you may also access the prospectus and prospectus supplement through the links
below:

·
Prospectus dated February 10, 2009:
http://www.sec.gov/Archives/edgar/data/312070/000119312509023285/dposasr.htm

·
Prospectus Supplement dated March 1, 2010:
http://www.sec.gov/Archives/edgar/data/312070/000119312510043357/d424b3.htm
Our Central Index Key, or CIK, on the SEC website is 1-10257.
Alternatively, Barclays Capital Inc. or any agent or dealer participating in this offering will arrange to send you this pricing supplement, the prospectus, the prospectus
supplement and any related free writing prospectus if you request it by calling your Barclays Capital Inc. sales representative, such dealer or 1-888-227-2275 (Extension
3430). A copy of the prospectus may be obtained from Barclays Capital Inc., 745 Seventh Avenue--Attn: US InvSol Support, New York, NY 10019.
You may revoke your offer to purchase the Notes at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the
terms of, or reject any offer to purchase the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will be asked to accept
such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.
As used in this term sheet, the "Company," "we," "us," or "our" refers to Barclays Bank PLC.
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 6 of 12
PROGRAM CREDIT RATING
The Notes are issued under the Global Medium-Term Notes Program, Series A (the "Program"). The Program is rated AA by Standard & Poor's Rating Services ("S&P"), and
the Notes are expected to carry the same S&P rating as the Program rating. An AA rating from S&P generally indicates that the issuer's capacity to meet its financial commitment
on the obligations arising from the Program is very strong. This rating does not take into account market risk or the performance-related risks of the investment (including, without
limitation, the risks associated with the potential negative performance of any reference asset to which the Notes are linked). The Program is also rated Aa3 by Moody's Investor
Services, Inc. ("Moody's"); however, because we have not sought a rating from Moody's for this specific issuance, the Notes will not be rated by Moody's. The ratings mentioned
in this paragraph are subject to downward revision, suspension or withdrawal at any time by the assigning rating organization and are not a recommendation to buy, sell or hold
securities.
SELECTED RISK FACTORS
An investment in the Notes involves significant risks. You should read the risks summarized below in connection with, and the risks summarized below are qualified by
reference to, the risks described in more detail in the "Risk Factors" section beginning on page S-5 of the prospectus supplement. We urge you to consult your
investment, legal, tax, accounting and other advisers and to invest in the Notes only after you and your advisors have carefully considered the suitability of an investment
in the Notes in light of your particular circumstances.

·
Issuer Credit Risk--You will receive at least 100% of the principal amount of your Notes if you hold your Notes to the Maturity Date. Because the Notes are our

senior unsecured obligations, payment of any interest or any amount at maturity is subject to our ability to pay our obligations as they become due.

·
Certain Built-In Costs Are Likely to Adversely Affect the Value of the Notes Prior to Maturity--Although you will not receive less than the principal amount
of the Notes if you hold the Notes to maturity, the Original Issue Price of the Notes includes the agent's commission and the cost of hedging our obligations under

the Notes through one or more of our affiliates. As a result, assuming no change in market conditions or any other relevant factor, the price, if any, at which Barclays
Capital Inc. and other affiliates of Barclays Bank PLC will be willing to purchase Notes from you in secondary market transactions may be lower than the Original
Issue Price, and any sale prior to the Maturity Date could result in a substantial loss to you.

·
Potential Conflicts--We and our affiliates play a variety of roles in connection with the issuance of the Notes, including hedging our obligations under the Notes. In

performing these duties, the economic interests of our affiliates of ours are potentially adverse to your interests as an investor in the Notes.
In addition, Barclays Wealth, the wealth management division of Barclays Capital Inc., may arrange for the sale of the Notes to certain of its clients. In doing so,
Barclays Wealth will be acting as agent for Barclays Bank PLC and may receive compensation from Barclays Bank PLC in the form of discounts and commissions.
The role of Barclays Wealth as a provider of certain services to such customers and as agent for Barclays Bank PLC in connection with the distribution of the Notes
to investors may create a potential conflict of interest, which may be adverse to such clients. Barclays Wealth is not acting as your agent or investment adviser, and is
not representing you in any capacity with respect to any purchase of Notes by you. Barclays Wealth is acting solely as agent for Barclays Bank PLC. If you are
considering whether to invest in the Notes through Barclays Wealth, we strongly urge you to seek independent financial and investment advice to assess the merits
of such investment.

·
Lack of Liquidity--The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make a
secondary market for the Notes but are not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if there is a
secondary market, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers are not likely to make a secondary market

for the Notes, the price at which you may be able to trade your Notes is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of
Barclays Bank PLC are willing to buy the Notes. The Notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing to
hold your Notes to maturity.

PS1
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 7 of 12
·
Many Economic and Market Factors Will Impact the Value of the Notes--The value of the Notes will be affected by a number of economic and market factors

that may either offset or magnify each other, including:

·
the time to maturity of the Notes;

·
interest and yield rates in the market generally;

·
a variety of economic, financial, political, regulatory or judicial events; and

·
our creditworthiness, including actual or anticipated downgrades in our credit ratings.
DESCRIPTION OF SURVIVOR'S OPTION
Upon request by the authorized representative of the beneficial owner of the Notes, Barclays Bank PLC will repay those Notes prior to the Maturity Date following the death of the
beneficial owner of the Notes (the "Survivor's Option"), provided such Notes were acquired by the deceased beneficial owner at least six months prior to the date of the request.
Upon the valid exercise of the Survivor's Option and the proper tender of the Notes for repayment, Barclays Bank PLC will repay such Notes, in whole or in part, at a price equal
to 100% of the principal amount of the deceased beneficial owner's beneficial interest in the Notes plus accrued and unpaid interest to the date of repayment. For purposes of this
section, a beneficial owner of Notes is a person who has the right, immediately prior to such person's death, to receive the proceeds from the disposition of such Notes, as well as
the right to receive payment of the principal of the Notes.
To be valid, the Survivor's Option must be exercised by or on behalf of the person who has authority to act on behalf of the deceased beneficial owner of the Notes under the laws
of the applicable jurisdiction (including, without limitation, the personal representative of or the executor of the estate of the deceased beneficial owner or the surviving joint owner
with the deceased beneficial owner).
The death of a person holding a beneficial ownership interest in the Notes: (1) with any person in a joint tenancy with right of survivorship; or (2) with his or her spouse in tenancy
by the entirety, tenancy in common, as community property or in any other joint ownership arrangement, will be deemed the death of a beneficial owner of those Notes, and the
entire principal amount of the Notes held in this manner will be subject to repayment by Barclays Bank PLC upon request. However, the death of a person holding a beneficial
ownership interest in Notes as tenant in common with a person other than his or her spouse will be deemed the death of a beneficial owner only with respect to such deceased
person's interest in the Notes, and only the deceased beneficial owner's percentage interest in the principal amount of the Notes will be subject to repayment.
If the ownership interest in the Notes is held by a nominee for a beneficial owner or by a custodian under a Uniform Gifts to Minors Act or Uniform Transfer to Minors Act, or by
a trustee of a trust that is wholly revocable by the beneficial owner, or by a guardian or committee for a beneficial owner, the death of the beneficial owner of the Notes will
constitute death of the beneficial owner for purposes of the Survivor's Option, if the beneficial ownership interest can be established to the satisfaction of Barclays Bank PLC. In
these cases, the death of the nominee, custodian, trustee, guardian or committee will not be deemed the death of the beneficial owner of the Notes for purposes of the Survivor's
Option.
Barclays Bank PLC has the discretionary right to limit the aggregate principal amount of the Notes as to which exercises of the Survivor's Option will be accepted by it from all
authorized representatives of deceased beneficial owners in any calendar year, to an amount equal to 2.0% of the aggregate amount of the Notes, outstanding as of the end of the
most recent calendar year.
Barclays Bank PLC also has the discretionary right to limit to $250,000 the aggregate principal amount of Notes as to which exercises of the Survivor's Option will be accepted by
Barclays Bank PLC from the authorized representative for any individual deceased beneficial owner of such notes in any calendar year. In addition, Barclays Bank PLC will not
permit the exercise of the Survivor's Option (a) for a principal amount less than $1,000, or (b) if such exercise will result in a beneficial ownership interest in a note with a
principal amount of less than $1,000 outstanding.
An otherwise valid election to exercise the Survivor's Option may not be withdrawn. Elections to exercise the Survivor's Option will be accepted in the order that they are received
and approved by Barclays Bank PLC, except for any election the acceptance of which would contravene any of the limitations described above. Notes accepted for repayment
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 8 of 12
through the exercise of the Survivor's Option will be repaid on the first Interest Payment Date that occurs 60 or more calendar days after the date of the acceptance and approval by
Barclays Bank PLC. Each tendered Note that is not accepted in any calendar year due to the application of any of the limitations described in the preceding paragraph will be
deemed to be tendered in the following calendar year in the order in which all such Notes were originally tendered. If a Note tendered through a valid exercise of the Survivor's
Option is not accepted by Barclays Bank PLC, the trustee, upon receipt of a valid written instruction from Barclays Bank PLC or its agent, will deliver a notice to the registered
holder that states the reason that Note has not been accepted for repayment.

PS2
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 9 of 12
Because the Notes will be issued in book-entry form (except in very limited circumstances), DTC or its nominee will be treated as the holder of the Notes, will be the only entity
that receives notices from Barclays Bank PLC (or the trustee) and, on behalf of the deceased beneficial owner's authorized representative, will be the only entity that can exercise
the Survivor's Option for such Notes. To obtain repayment of the Notes pursuant to exercise of the Survivor's Option, the deceased beneficial owner's authorized representative
must provide the following items to the broker or other entity through which the beneficial interest in the Notes is held by the deceased beneficial owner:

·
appropriate evidence satisfactory to Barclays Bank PLC that:

(1)
the deceased was the beneficial owner of the Notes at the time of death and his or her interest in the Notes was acquired by the deceased beneficial owner at

least six months prior to the request for repayment,

(2)
the death of the beneficial owner has occurred and the date of death, and

(3)
the representative has authority to act on behalf of the deceased beneficial owner;

·
if the beneficial interest in the Notes is held by a nominee or trustee of, custodian for, or other person in a similar capacity to, the deceased beneficial owner,

evidence satisfactory to Barclays Bank PLC from the nominee, trustee, custodian or similar person attesting to the deceased's beneficial ownership of that Notes;

·
a written request for repayment signed by the authorized representative of the deceased beneficial owner with the signature guaranteed by a firm that is a participant
in the Security Transfer Agents Medallion Program, the New York Stock Exchange Medallion Signature Program or the Stock Exchange Medallion Program

(generally a member of a registered national securities exchange, a member of the Financial Industry Regulatory Authority, or a commercial bank or trust company
having an office in the United States);

·
tax waivers and any other instruments or documents that Barclays Bank PLC reasonably requires in order to establish the validity of the beneficial ownership of the

Notes and the claimant's entitlement to payment; and

·
any additional information Barclays Bank PLC requires to evidence satisfaction of any conditions to the exercise of the Survivor's Option or to document beneficial

ownership or authority to make the election and to cause the repayment of the Notes.
In turn, the broker or other entity will deliver each of these items, through the appropriate direct participant in DTC and the facilities of DTC will deliver the Survivor's Option
Form of Notice, to the trustee and to Barclays Bank PLC and will certify to Barclays Bank PLC that the broker or other entity represents the deceased beneficial owner. The broker
or other entity will be responsible for disbursing payments received from the trustee, through the facilities of DTC, to the authorized representative.
During any time in which the Notes are not represented by a global note and are issued in definitive form:

·
all references in this section to participants and DTC, including the DTC's governing rules, regulations and procedures, will be deemed inapplicable;

·
all determinations that the DTC participants are required to make as described in this section will be made by Barclays Bank PLC, including, without limitation,
determining whether the applicable decedent is in fact the beneficial owner of the interest in the Notes to be redeemed or is in fact deceased and whether the representative
is duly authorized to request redemption on behalf of the applicable beneficial owner; and

·
all redemption requests, to be effective, must:

· be delivered by the representative to Barclays Bank PLC and to the trustee;

· be in the form of the attached to this pricing supplement, and must be completed in accordance with the related instructions; and

· be accompanied by, if applicable, a properly executed assignment or endorsement, in addition to all documents that are otherwise required to

accompany a redemption request. If the record holder of the Note is a nominee of the deceased beneficial owner, a certificate or letter from the
nominee attesting to the deceased's ownership of a beneficial interest in the Note must also be delivered.
Barclays Bank PLC retains the right to limit the aggregate principal amount of Notes as to which exercises of the Survivor's Option will be accepted from all authorized
representatives of deceased beneficial owners and from the authorized representative for any individual deceased beneficial owner in any one calendar year as described above. All
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010

Pricing Supplement BARC 13yr 5.00% with Survivor's Option Black
Page 10 of 12
other questions regarding the eligibility or validity of any exercise of the Survivor's Option generally will be determined by Barclays Bank PLC, which determination will be final
and binding on all parties.
Forms for the exercise of the Survivor's Option may be obtained from Barclays Bank PLC, 745 Seventh Avenue, New York, NY 10019, Attention: US-Syndicate,MTN Desk US,
telephone: 212-412-1535.

PS3
http://www.sec.gov/Archives/edgar/data/312070/000119312510094777/d424b2.htm
4/27/2010